Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women
Azmi A. Nabulsi, Aaron R. Folsom, Alice White, Wolfgang Patsch, Gerardo Heiss, Kenneth K. Wu, Moyses Szklo, for The Atherosclerosis Risk in Communities Study Investigators
Background Most epidemiologic studies of cardiovascular diseasein postmenopausal women suggest that estrogen-replacement therapyhas a protective effect. The effects of the use of estrogencombined with progestin are less well studied.
Methods To examine the associations of hormone-replacement therapywith concentrations of plasma lipids and hemostatic factors,fasting serum concentrations of glucose and insulin, and bloodpressure, we studied 4958 postmenopausal women participatingin a population-based investigation. Using cross-sectional data,we classified the women into four groups according to theiruse of hormone-replacement therapy: current users of estrogenalone, current users of estrogen with progestin, nonusers whohad formerly used these hormones, and nonusers who had neverused them.
Results Current users had higher mean levels of high-densitylipoprotein cholesterol, its subfractions high-density lipoprotein2and high-density lipoprotein3, and apolipoprotein A-I than nonusers,and lower mean levels of low-density lipoprotein cholesterol,apolipoprotein B, lipoprotein(a), fibrinogen, antithrombin III,and fasting serum glucose and insulin. However, current usersof estrogen alone had higher triglyceride, factor VII, and proteinC levels than either nonusers or current users of estrogen withprogestin. After making certain assumptions, we estimated thatthe findings, if causal, would translate into a reduction of42 percent in the risk of coronary heart disease in users ofhormones as compared with nonusers. Women using estrogen withprogestin would have an even greater estimated benefit.
Conclusions A randomized trial is needed to eliminate possibleselection biases in our observational study that are relatedto the prescription of replacement hormones. Nevertheless, hormone-replacementtherapy appears to be associated with a favorable physiologicprofile, which probably mediates its protective effects on cardiovasculardisease. The use of estrogen combined with progestin appearsto be associated with a better profile than the use of estrogenalone.
Source Information
From the Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis (A.A.N., A.R.F.); the ESP Division, Burroughs-Wellcome Company, Research Triangle Park, N.(A.W.); the Atherosclerosis Clinical Laboratory, Methodist Hospital, Houston (W.P.); the School of Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill (G.H.); the Division of Hematology-Oncology, University of Texas Medical School, Houston (K.K.W.); and the Johns Hopkins School of Hygiene and Public Health, Baltimore (M.S.).
Address reprint requests to Dr. Folsom at the Division of Epidemiology, School of Public Health, University of Minnesota, 1300 S. Second St., Suite 300, Minneapolis, MN 55454.
Schreckenberg, R., Wenzel, S., da Costa Rebelo, R. M., Rothig, A., Meyer, R., Schluter, K.-D.
(2009). Cell-Specific Effects of Nitric Oxide Deficiency on Parathyroid Hormone-Related Peptide (PTHrP) Responsiveness and PTH1 Receptor Expression in Cardiovascular Cells. Endocrinology
150: 3735-3741
[Abstract][Full Text]
Kim, D.-J., Barrett-Connor, E.
(2006). Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the rancho bernardo study.. Diabetes Care
29: 618-624
[Abstract][Full Text]
Kappert, K., Caglayan, E., Huntgeburth, M., Baumer, A. T., Sparwel, J., Uebel, M., Rosenkranz, S.
(2006). 17{beta}-Estradiol attenuates PDGF signaling in vascular smooth muscle cells at the postreceptor level. Am. J. Physiol. Heart Circ. Physiol.
290: H538-H546
[Abstract][Full Text]
Wassmann, K., Wassmann, S., Nickenig, G.
(2005). Progesterone Antagonizes the Vasoprotective Effect of Estrogen on Antioxidant Enzyme Expression and Function. Circ. Res.
97: 1046-1054
[Abstract][Full Text]
Sowers, M. R., Matthews, K. A., Jannausch, M., Randolph, J. F., McConnell, D., Sutton-Tyrrell, K., Little, R., Lasley, B., Pasternak, R.
(2005). Hemostatic Factors and Estrogen during the Menopausal Transition. J. Clin. Endocrinol. Metab.
90: 5942-5948
[Abstract][Full Text]
Fan, Y.-M., Dastidar, P., Jokela, H., Punnonen, R., Lehtimaki, T.
(2005). Hepatic Lipase C-480T Genotype-Dependent Benefit from Long-Term Hormone Replacement Therapy for Atherosclerosis Progression in Postmenopausal Women. J. Clin. Endocrinol. Metab.
90: 3786-3792
[Abstract][Full Text]
Kellokoski, E., Poykko, S. M., Karjalainen, A. H., Ukkola, O., Heikkinen, J., Kesaniemi, Y. A., Horkko, S.
(2005). Estrogen Replacement Therapy Increases Plasma Ghrelin Levels. J. Clin. Endocrinol. Metab.
90: 2954-2963
[Abstract][Full Text]
Dubey, R. K., Imthurn, B., Barton, M., Jackson, E. K.
(2005). Vascular consequences of menopause and hormone therapy: Importance of timing of treatment and type of estrogen. Cardiovasc Res
66: 295-306
[Abstract][Full Text]
Mudali, S., Dobs, A. S., Ding, J., Cauley, J. A., Szklo, M., Golden, S. H.
(2005). Endogenous Postmenopausal Hormones and Serum Lipids: The Atherosclerosis Risk in Communities Study. J. Clin. Endocrinol. Metab.
90: 1202-1209
[Abstract][Full Text]
Nguyen, L., Liles, D. R., Lin, P. H., Bush, R. L.
(2004). Hormone Replacement Therapy and Peripheral Vascular Disease in Women. VASC ENDOVASCULAR SURG
38: 547-556
[Abstract]
Bain, C.A.L., Walters, M.R., Lees, K.R., Lumsden, M.A.
(2004). The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. Hum Reprod
19: 2411-2414
[Abstract][Full Text]
Honisett, S. Y., Stojanovska, L., Sudhir, K., Kingwell, B. A., Dawood, T., Komesaroff, P. A.
(2004). Hormone Therapy Impairs Endothelial Function in Postmenopausal Women with Type 2 Diabetes Mellitus Treated with Rosiglitazone. J. Clin. Endocrinol. Metab.
89: 4615-4619
[Abstract][Full Text]
Alecrin, I N, Aldrighi, J M, Caldas, M A, Gebara, O C E, Lopes, N H M, Ramires, J A F
(2004). Acute and chronic effects of oestradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart
90: 777-781
[Abstract][Full Text]
Petitti, D.
(2004). Commentary: Hormone replacement therapy and coronary heart disease: four lessons. Int J Epidemiol
33: 461-463
[Full Text]
Sagara, M., Kanda, T., NJelekera, M., Teramoto, T., Armitage, L., Birt, N., Birt, C., Yamori, Y.
(2004). Effects of Dietary Intake of Soy Protein and Isoflavones on Cardiovascular Disease Risk Factors in High Risk, Middle-Aged Men in Scotland. J. Am. Coll. Nutr.
23: 85-91
[Abstract][Full Text]
Mericli, M., Nadasy, G. L., Szekeres, M., Varbiro, S., Vajo, Z., Matrai, M., Acs, N., Monos, E., Szekacs, B.
(2004). Estrogen replacement therapy reverses changes in intramural coronary resistance arteries caused by female sex hormone depletion. Cardiovasc Res
61: 317-324
[Abstract][Full Text]
Spence, J. D., Thornton, T., Muir, A. D., Westcott, N. D.
(2003). The Effect of Flax Seed Cultivars with Differing Content of {alpha}-Linolenic Acid and Lignans on Responses to Mental Stress. J. Am. Coll. Nutr.
22: 494-501
[Abstract][Full Text]
Sowers, M., Derby, C., Jannausch, M. L., Torrens, J. I., Pasternak, R.
(2003). Insulin Resistance, Hemostatic Factors, and Hormone Interactions in Pre- and Perimenopausal Women: SWAN. J. Clin. Endocrinol. Metab.
88: 4904-4910
[Abstract][Full Text]
Newton, K. M., LaCroix, A. Z., Heckbert, S. R., Abraham, L., McCulloch, D., Barlow, W.
(2003). Estrogen Therapy and Risk of Cardiovascular Events Among Women With Type 2 Diabetes. Diabetes Care
26: 2810-2816
[Abstract][Full Text]
Makela, R., Dastidar, P., Jokela, H., Saarela, M., Punnonen, R., Lehtimaki, T.
(2003). Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Myeloperoxidase Promoter Polymorphism. J. Clin. Endocrinol. Metab.
88: 3823-3828
[Abstract][Full Text]
Garcia Pedrero, J. M., Zuazua, P., Martinez-Campa, C., Lazo, P. S., Ramos, S.
(2003). The Naturally Occurring Variant of Estrogen Receptor (ER) ER{Delta}E7 Suppresses Estrogen-Dependent Transcriptional Activation by Both Wild-Type ER{alpha} and ER{beta}. Endocrinology
144: 2967-2976
[Abstract][Full Text]
Wu, Z., Maric, C., Roesch, D. M., Zheng, W., Verbalis, J. G., Sandberg, K.
(2003). Estrogen Regulates Adrenal Angiotensin AT1 Receptors by Modulating AT1 Receptor Translation. Endocrinology
144: 3251-3261
[Abstract][Full Text]
Okada, M., Nomura, S., Ikoma, Y., Yamamoto, E., Ito, T., Mitsui, T., Tamakoshi, K., Mizutani, S.
(2003). Effects of Postmenopausal Hormone Replacement Therapy on HbA1c Levels. Diabetes Care
26: 1088-1092
[Abstract][Full Text]
Kanaya, A. M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V., Cauley, J. A., Barrett-Connor, E.
(2003). Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial. ANN INTERN MED
138: 1-9
[Abstract][Full Text]
Kuller, L. H.
(2003). Hormone Replacement Therapy and Risk of Cardiovascular Disease: Implications of the Results of the Women's Health Initiative. Arterioscler. Thromb. Vasc. Bio.
23: 11-16
[Abstract][Full Text]
Bladbjerg, E.M., Skouby, S.O., Andersen, L.F., Jespersen, J.
(2002). Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Hum Reprod
17: 3235-3241
[Abstract][Full Text]
Barkhem, T., Haldosen, L.-A., Gustafsson, J.-A., Nilsson, S.
(2002). Transcriptional Synergism on the pS2 Gene Promoter between a p160 Coactivator and Estrogen Receptor-{alpha} Depends on the Coactivator Subtype, the Type of Estrogen Response Element, and the Promoter Context. Mol. Endocrinol.
16: 2571-2581
[Abstract][Full Text]
Armando, I., Jezova, M., Juorio, A. V., Terron, J. A., Falcon-Neri, A., Semino-Mora, C., Imboden, H., Saavedra, J. M.
(2002). Estrogen upregulates renal angiotensin II AT2 receptors. Am. J. Physiol. Renal Physiol.
283: F934-F943
[Abstract][Full Text]
Sanada, M., Higashi, Y., Nakagawa, K., Tsuda, M., Kodama, I., Kimura, M., Chayama, K., Ohama, K.
(2002). Hormone Replacement Effects on Endothelial Function Measured in the Forearm Resistance Artery in Normocholesterolemic and Hypercholesterolemic Postmenopausal Women. J. Clin. Endocrinol. Metab.
87: 4634-4641
[Abstract][Full Text]
Lehtimaki, T., Dastidar, P., Jokela, H., Koivula, T., Lehtinen, S., Ehnholm, C., Punnonen, R.
(2002). Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype. J. Clin. Endocrinol. Metab.
87: 4147-4153
[Abstract][Full Text]
Simoncini, T., Varone, G., Fornari, L., Mannella, P., Luisi, M., Labrie, F., Genazzani, A. R.
(2002). Genomic and Nongenomic Mechanisms of Nitric Oxide Synthesis Induction in Human Endothelial Cells by a Fourth-Generation Selective Estrogen Receptor Modulator. Endocrinology
143: 2052-2061
[Abstract][Full Text]
Zhang, Y., Howard, B. V., Cowan, L. D., Yeh, J., Schaefer, C. F., Wild, R. A., Wang, W., Lee, E. T.
(2002). The Effect of Estrogen Use on Levels of Glucose and Insulin and the Risk of Type 2 Diabetes in American Indian Postmenopausal Women : The Strong Heart Study. Diabetes Care
25: 500-504
[Abstract][Full Text]
Golden, S. H., Maguire, A., Ding, J., Crouse, J. R., Cauley, J. A., Zacur, H., Szklo, M.
(2002). Endogenous Postmenopausal Hormones and Carotid Atherosclerosis: A Case-Control Study of the Atherosclerosis Risk in Communities Cohort. Am J Epidemiol
155: 437-445
[Abstract][Full Text]
Mikkola, T. S, Clarkson, T. B
(2002). Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res
53: 605-619
[Abstract][Full Text]
Nakano, Y., Oshima, T., Ozono, R., Ueda, A., Oue, Y., Matsuura, H., Sanada, M., Ohama, K., Chayama, K., Kambe, M.
(2002). Estrogen replacement suppresses function of thrombin stimulated platelets by inhibiting Ca2+ influx and raising cyclic adenosine monophosphate. Cardiovasc Res
53: 634-641
[Abstract][Full Text]
Dubey, R. K., Oparil, S., Imthurn, B., Jackson, E. K.
(2002). Sex hormones and hypertension. Cardiovasc Res
53: 688-708
[Abstract][Full Text]
Hundrup, Y. A., Thoning, H., Obel, E. B., Rasmussen, N. K., Philip, J.
(2002). Lifestyle factors and choice of hormone replacement therapy among Danish nurses. Scand J Public Health
30: 47-53
[Abstract]
Vega-Lopez, S., Vidal-Quintanar, R. L., Fernandez, M. L.
(2001). Sex and hormonal status influence plasma lipid responses to psyllium. Am. J. Clin. Nutr.
74: 435-441
[Abstract][Full Text]
Dubey, R. K., Jackson, E. K.
(2001). Genome and Hormones: Gender Differences in Physiology: Invited Review: Cardiovascular protective effects of 17{beta}-estradiol metabolites. J. Appl. Physiol.
91: 1868-1883
[Abstract][Full Text]
Herrington, D. M., Brosnihan, K. B., Pusser, B. E., Seely, E. W., Ridker, P. M., Rifai, N., MacLean, D. B.
(2001). Differential Effects of E and Droloxifene on C-Reactive Protein and Other Markers of Inflammation in Healthy Postmenopausal Women. J. Clin. Endocrinol. Metab.
86: 4216-4222
[Abstract][Full Text]
Manning, P. J., Allum, A., Jones, S., Sutherland, W. H. F., Williams, S. M.
(2001). The Effect of Hormone Replacement Therapy on Cardiovascular Risk Factors in Type 2 Diabetes: A Randomized Controlled Trial. Arch Intern Med
161: 1772-1776
[Abstract][Full Text]
Grady, D., Hulley, S. B.
(2001). Postmenopausal hormones and heart disease. J Am Coll Cardiol
38: 8-10
[Full Text]
Brighouse, D.
(2001). Hormone replacement therapy (HRT) and anaesthesia. Br J Anaesth
86: 709-716
[Abstract][Full Text]
Al-Azzawi, F
(2001). The menopause and its treatment in perspective. Postgrad. Med. J.
77: 292-304
[Full Text]
Goodman-Gruen, D., Kritz-Silverstein, D.
(2001). Usual Dietary Isoflavone Intake Is Associated with Cardiovascular Disease Risk Factors in Postmenopausal Women. J. Nutr.
131: 1202-1206
[Abstract][Full Text]
Young, T.
(2001). Menopause, Hormone Replacement Therapy, and Sleep-disordered Breathing . Are We Ready for the Heat?. Am. J. Respir. Crit. Care Med.
163: 597-598
[Full Text]
Dubey, R. K., Jackson, E. K.
(2001). Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am. J. Physiol. Renal Physiol.
280: F365-F388
[Abstract][Full Text]
Bittner, V.
(2001). Estrogens, lipids and cardiovascular disease: no easy answers. J Am Coll Cardiol
37: 431-433
[Full Text]
Higashi, Y., Sanada, M., Sasaki, S., Nakagawa, K., Goto, C., Matsuura, H., Ohama, K., Chayama, K., Oshima, T.
(2001). Effect of Estrogen Replacement Therapy on Endothelial Function in Peripheral Resistance Arteries in Normotensive and Hypertensive Postmenopausal Women. Hypertension
37: 651-657
[Abstract][Full Text]
Wassmann, S., Baumer, A. T., Strehlow, K., van Eickels, M., Grohe, C., Ahlbory, K., Rosen, R., Bohm, M., Nickenig, G.
(2001). Endothelial Dysfunction and Oxidative Stress During Estrogen Deficiency in Spontaneously Hypertensive Rats. Circulation
103: 435-441
[Abstract][Full Text]
Peverill, R.
(2001). Hormone Therapy and Risk for Venous Thromboembolism: Comments and Correction. ANN INTERN MED
134: 80-80
[Full Text]
Nickenig, G., Strehlow, K., Wassmann, S., Baumer, A. T., Albory, K., Sauer, H., Bohm, M.
(2000). Differential Effects of Estrogen and Progesterone on AT1 Receptor Gene Expression in Vascular Smooth Muscle Cells. Circulation
102: 1828-1833
[Abstract][Full Text]
Rosvall, M., Ostergren, P. O., Hedblad, B., Isacsson, S-O., Janzon, L., Berglund, G.
(2000). Occupational Status, Educational Level, and the Prevalence of Carotid Atherosclerosis in a General Population Sample of Middle-aged Swedish Men and Women: Results from the Malmo Diet and Cancer Study. Am J Epidemiol
152: 334-346
[Abstract][Full Text]
Thompson, L. P., Pinkas, G., Weiner, C. P.
(2000). Chronic 17{beta}-Estradiol Replacement Increases Nitric Oxide-Mediated Vasodilation of Guinea Pig Coronary Microcirculation. Circulation
102: 445-451
[Abstract][Full Text]
Rosenfeld, C. R., White, R. E., Roy, T., Cox, B. E.
(2000). Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation. Am. J. Physiol. Heart Circ. Physiol.
279: H319-H328
[Abstract][Full Text]
Herrington, D. M., Pusser, B. E., Riley, W. A., Thuren, T. Y., Brosnihan, K. B., Brinton, E. A., MacLean, D. B.
(2000). Cardiovascular Effects of Droloxifene, a New Selective Estrogen Receptor Modulator, in Healthy Postmenopausal Women. Arterioscler. Thromb. Vasc. Bio.
20: 1606-1612
[Abstract][Full Text]
Grady, D., Wenger, N. K., Herrington, D., Khan, S., Furberg, C., Hunninghake, D., Vittinghoff, E., Hulley, S., for the Heart and Estrogen/progestin Replacement S,
(2000). Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study. ANN INTERN MED
132: 689-696
[Abstract][Full Text]
Agerholm-Larsen, B., Nordestgaard, B. G., Steffensen, R., Jensen, G., Tybjarg-Hansen, A.
(2000). Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene. Circulation
101: 1907-1912
[Abstract][Full Text]
Greaves, K. A., Wilson, M. D., Rudel, L. L., Williams, J. K., Wagner, J. D.
(2000). Consumption of Soy Protein Reduces Cholesterol Absorption Compared to Casein Protein Alone or Supplemented with an Isoflavone Extract or Conjugated Equine Estrogen in Ovariectomized Cynomolgus Monkeys. J. Nutr.
130: 820-826
[Abstract][Full Text]
Hayashi, T., Esaki, T., Muto, E., Kano, H., Asai, Y., Thakur, N. K., Sumi, D., Jayachandran, M., Iguchi, A.
(2000). Dehydroepiandrosterone Retards Atherosclerosis Formation Through Its Conversion to Estrogen : The Possible Role of Nitric Oxide. Arterioscler. Thromb. Vasc. Bio.
20: 782-792
[Abstract][Full Text]
Acs, N., Vajo, Z., Miklos, Z., Siklósi, G., Paulin, F., Szekacs, B.
(2000). Postmenopausal Hormone Replacement Therapy and Cardiovascular Mortality in Central-Eastern Europe. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
55: 160M-162
[Abstract][Full Text]
Burke, G. L., Vitolins, M. Z., Bland, D.
(2000). Soybean Isoflavones as an Alternative to Traditional Hormone Replacement Therapy: Are We There Yet?. J. Nutr.
130: 664-664
[Full Text]
Kanamori, H., Krieg, S., Mao, C., Di Pippo, V. A., Wang, S., Zajchowski, D. A., Shapiro, D. J.
(2000). Proteinase Inhibitor 9, an Inhibitor of Granzyme B-mediated Apoptosis, Is a Primary Estrogen-inducible Gene in Human Liver Cells. J. Biol. Chem.
275: 5867-5873
[Abstract][Full Text]
Fak, A.S, Erenus, M, Tezcan, H, Caymaz, O, AtagunduZ, P, Oktay, S, Oktay, A
(2000). Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on serum lipid levels in hypercholesterolaemic post-menopausal women. Eur Heart J
21: 190-197
[Abstract]
McCrohon, J. A., Nakhla, S., Jessup, W., Stanley, K. K., Celermajer, D. S.
(1999). Estrogen and Progesterone Reduce Lipid Accumulation in Human Monocyte-Derived Macrophages : A Sex-Specific Effect. Circulation
100: 2319-2325
[Abstract][Full Text]
Guerra, S., Leri, A., Wang, X., Finato, N., Di Loreto, C., Beltrami, C. A., Kajstura, J., Anversa, P.
(1999). Myocyte Death in the Failing Human Heart Is Gender Dependent. Circ. Res.
85: 856-866
[Abstract][Full Text]
Cushman, M., Legault, C., Barrett-Connor, E., Stefanick, M. L., Kessler, C., Judd, H. L., Sakkinen, P. A., Tracy, R. P.
(1999). Effect of Postmenopausal Hormones on Inflammation-Sensitive Proteins : The Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation
100: 717-722
[Abstract][Full Text]
Greaves, K. A., Parks, J. S., Williams, J. K., Wagner, J. D.
(1999). Intact Dietary Soy Protein, but Not Adding an Isoflavone-Rich Soy Extract to Casein, Improves Plasma Lipids in Ovariectomized Cynomolgus Monkeys. J. Nutr.
129: 1585-1592
[Abstract][Full Text]
Harada, N., Sasano, H., Murakami, H., Ohkuma, T., Nagura, H., Takagi, Y.
(1999). Localized Expression of Aromatase in Human Vascular Tissues. Circ. Res.
84: 1285-1291
[Abstract][Full Text]
Mendelsohn, M. E., Karas, R. H.
(1999). The Protective Effects of Estrogen on the Cardiovascular System. NEJM
340: 1801-1811
[Full Text]
Gapstur, S. M., Morrow, M., Sellers, T. A.
(1999). Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology: Results of the Iowa Women's Health Study. JAMA
281: 2091-2097
[Abstract][Full Text]
Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O'Rourke, R. A., Schafer, W. P., Williams, S. V., Ritchie, J. L., Gibbons, R. J., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Russell, R. O., Ryan, T. J., Smith, S. C. Jr
(1999). ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol
33: 2092-2197
[Full Text]
Crawford, S. L., Johannes, C. B.
(1999). The Epidemiology of Cardiovascular Disease in Postmenopausal Women. J. Clin. Endocrinol. Metab.
84: 1803-1806
[Full Text]
Cagnacci, A., Rovati, L., Zanni, A., Malmusi, S., Facchinetti, F., Volpe, A.
(1999). Physiological doses of estradiol decrease nocturnal blood pressure in normotensive postmenopausal women. Am. J. Physiol. Heart Circ. Physiol.
276: H1355-H1360
[Abstract][Full Text]
Nilausen, K., Meinertz, H.
(1999). Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein. Am. J. Clin. Nutr.
69: 419-425
[Abstract][Full Text]
Steffen, A. M., Thompson, L. W., Gallagher-Thompson, D., Koin, D.
(1999). Physical and Psychosocial Correlates of Hormone Replacement Therapy with Chronically Stressed Postmenopausal Women. J Aging Health
11: 3-26
[Abstract]
Zandberg, P., Peters, J. L. M., Demacker, P. N. M., Smit, M. J., de Reeder, E. G., Meuleman, D. G.
(1998). Tibolone Prevents Atherosclerotic Lesion Formation in Cholesterol-Fed, Ovariectomized Rabbits. Arterioscler. Thromb. Vasc. Bio.
18: 1844-1854
[Abstract][Full Text]
Sbarouni, E., Kyriakides, Z. S., Kremastinos, D. T.
(1998). The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease. J Am Coll Cardiol
32: 1244-1250
[Abstract][Full Text]
Schillaci, G., Verdecchia, P., Borgioni, C., Ciucci, A., Porcellati, C.
(1998). Early Cardiac Changes After Menopause. Hypertension
32: 764-769
[Abstract][Full Text]
Weintraub, M. S., Grosskopf, I., Charach, G., Eckstein, N., Ringel, Y., Maharshak, N., Rotmensch, H. H., Rubinstein, A.
(1998). Fluctuations of Lipid and Lipoprotein Levels in Hyperlipidemic Postmenopausal Women Receiving Hormone Replacement Therapy. Arch Intern Med
158: 1803-1806
[Abstract][Full Text]
Chaidarun, S. S., Alexander, J. M.
(1998). A Tumor-Specific Truncated Estrogen Receptor Splice Variant Enhances Estrogen-Stimulated Gene Expression. Mol. Endocrinol.
12: 1355-1366
[Abstract][Full Text]
Gebara, O C E, Mittleman, M A, Walsh, B W, Lipinska, I, Welty, F K, Bellotti, G, Muller, J E, Sacks, F K, Tofler, G H
(1998). Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart
80: 235-239
[Abstract][Full Text]
Magness, R. R., Phernetton, T. M., Zheng, J.
(1998). Systemic and uterine blood flow distribution during prolonged infusion of 17beta -estradiol. Am. J. Physiol. Heart Circ. Physiol.
275: H731-H743
[Abstract][Full Text]
Westerveld, H. T., van Lennep, J. E. R., van Lennep, H. W. O. R., Liem, A.-H., de Boo, J. A. J., van der Schouw, Y. T., Erkelens, D. W.
(1998). Apolipoprotein B and Coronary Artery Disease in Women : A Cross-sectional Study in Women Undergoing Their First Coronary Angiography. Arterioscler. Thromb. Vasc. Bio.
18: 1101-1107
[Abstract][Full Text]
McGrath, B. P., Liang, Y.-L., Teede, H., Shiel, L. M., Cameron, J. D., Dart, A.
(1998). Age-Related Deterioration in Arterial Structure and Function in Postmenopausal Women : Impact of Hormone Replacement Therapy. Arterioscler. Thromb. Vasc. Bio.
18: 1149-1156
[Abstract][Full Text]
British Cardiac Society, , British Hyperlipidaemia Association, , British Hypertension Society, , endorsed by the British Diabetic Association,
(1998). Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart
80: 1S-29
[Full Text]
Nickenig, G., Baumer, A. T., Grohe, C., Kahlert, S., Strehlow, K., Rosenkranz, S., Stablein, A., Beckers, F., Smits, J. F. M., Daemen, M. J. A. P., Vetter, H., Bohm, M.
(1998). Estrogen Modulates AT1 Receptor Gene Expression In Vitro and In Vivo. Circulation
97: 2197-2201
[Abstract][Full Text]
Hernandez, I., Delgado, J. L., Carbonell, L. F., Perez, M. C., Quesada, T.
(1998). Hemodynamic effect of 17beta -estradiol in absence of NO in ovariectomized rats: role of angiotensin II. Am. J. Physiol. Regul. Integr. Comp. Physiol.
274: R970-R978
[Abstract][Full Text]
Zeigler-Johnson, C. M., Holmes, J. L., Lassila, H. C., Sutton-Tyrrell, K., Kuller, L. H.
(1998). Subclinical Atherosclerosis in Relation to Hysterectomy Status in Black Women. Stroke
29: 759-764
[Abstract][Full Text]
Van Belle, E., Bauters, C., Asahara, T., Isner, J. M.
(1998). Endothelial regrowth after arterial injury: from vascular repair to therapeutics. Cardiovasc Res
38: 54-68
[Full Text]
Espeland, M. A., Marcovina, S. M., Miller, V., Wood, P. D., Wasilauskas, C., Sherwin, R., Schrott, H., Bush, T. L.
(1998). Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration. Circulation
97: 979-986
[Abstract][Full Text]
Clarkson, T. B., Anthony, M. S., Jerome, C. P.
(1998). Lack of Effect of Raloxifene on Coronary Artery Atherosclerosis of Postmenopausal Monkeys. J. Clin. Endocrinol. Metab.
83: 721-726
[Abstract][Full Text]
Wagner, J. D., Thomas, M. J., Williams, J. K., Zhang, L., Greaves, K. A., Cefalu, W. T.
(1998). Insulin Sensitivity and Cardiovascular Risk Factors in Ovariectomized Monkeys with Estradiol Alone or Combined with Nomegestrol Acetate. J. Clin. Endocrinol. Metab.
83: 896-901
[Abstract][Full Text]
Huang, A., Sun, D., Kaley, G., Koller, A.
(1998). Estrogen Preserves Regulation of Shear Stress by Nitric Oxide in Arterioles of Female Hypertensive Rats. Hypertension
31: 309-314
[Abstract][Full Text]
Skafar, D. F., Xu, R., Morales, J., Ram, J., Sowers, J. R.
(1997). Female Sex Hormones and Cardiovascular Disease in Women. J. Clin. Endocrinol. Metab.
82: 3913-3918
[Abstract][Full Text]
Masini, E., Bani, D., Bello, M. G., Bigazzi, M., Mannaioni, P. F., Sacchi, T. B.
(1997). Relaxin Counteracts Myocardial Damage Induced by Ischemia-Reperfusion in Isolated Guinea Pig Hearts: Evidence for an Involvement of Nitric Oxide. Endocrinology
138: 4713-4720
[Abstract][Full Text]
Scarabin, P.-Y., Alhenc-Gelas, M., Plu-Bureau, G., Taisne, P., Agher, R., Aiach, M.
(1997). Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial. Arterioscler. Thromb. Vasc. Bio.
17: 3071-3078
[Abstract][Full Text]
Wang, X., Barber, D. A., Lewis, D. A., McGregor, C. G. A., Sieck, G. C., Fitzpatrick, L. A., Miller, V. M.
(1997). Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol.
273: H1962-H1967
[Abstract][Full Text]
Croston, G. E., Milan, L. B., Marschke, K. B., Reichman, M., Briggs, M. R.
(1997). Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes. Endocrinology
138: 3779-3786
[Abstract][Full Text]
McNagny, S. E., Jacobson, T. A.
(1997). Use of Postmenopausal Hormone Replacement Therapy by African American Women: The Importance of Physician Discussion. Arch Intern Med
157: 1337-1342
[Abstract]
(A.W.); the Atherosclerosis Clinical Laboratory, Methodist Hospital, Houston (W.P.); the School of Public Health, Department of Epidemiology, University of North Carolina, Chapel Hill (G.H.); the Division of Hematology-Oncology, University of Texas Medical School, Houston (K.K.W.); and the Johns Hopkins School of Hygiene and Public Health, Baltimore (M.S.).
